Head-To-Head Contrast: Vivani Medical (VANI) & Its Competitors

Vivani Medical (NASDAQ:VANIGet Free Report) is one of 69 publicly-traded companies in the “Electromedical equipment” industry, but how does it weigh in compared to its rivals? We will compare Vivani Medical to similar businesses based on the strength of its dividends, analyst recommendations, risk, institutional ownership, profitability, valuation and earnings.

Analyst Recommendations

This is a summary of current ratings for Vivani Medical and its rivals, as provided by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Vivani Medical 0 0 1 0 3.00
Vivani Medical Competitors 152 646 1789 94 2.68

Vivani Medical presently has a consensus target price of $7.00, suggesting a potential upside of 636.84%. As a group, “Electromedical equipment” companies have a potential upside of 56.73%. Given Vivani Medical’s stronger consensus rating and higher probable upside, equities research analysts clearly believe Vivani Medical is more favorable than its rivals.

Earnings & Valuation

This table compares Vivani Medical and its rivals top-line revenue, earnings per share and valuation.

Gross Revenue Net Income Price/Earnings Ratio
Vivani Medical N/A -$13.89 million -2.44
Vivani Medical Competitors $1.02 billion $86.23 million 4.79

Vivani Medical’s rivals have higher revenue and earnings than Vivani Medical. Vivani Medical is trading at a lower price-to-earnings ratio than its rivals, indicating that it is currently more affordable than other companies in its industry.

Volatility and Risk

Vivani Medical has a beta of 2.64, meaning that its stock price is 164% more volatile than the S&P 500. Comparatively, Vivani Medical’s rivals have a beta of 13.18, meaning that their average stock price is 1,218% more volatile than the S&P 500.


This table compares Vivani Medical and its rivals’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Vivani Medical N/A -44.95% -35.23%
Vivani Medical Competitors -429.39% -126.18% -35.53%

Insider and Institutional Ownership

8.4% of Vivani Medical shares are held by institutional investors. Comparatively, 45.9% of shares of all “Electromedical equipment” companies are held by institutional investors. 55.6% of Vivani Medical shares are held by insiders. Comparatively, 10.6% of shares of all “Electromedical equipment” companies are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.


Vivani Medical beats its rivals on 7 of the 13 factors compared.

Vivani Medical Company Profile

(Get Free Report)

Vivani Medical, Inc., a clinical stage company, develops various implants that treat chronic diseases with high unmet medical need. It engages in developing a portfolio of miniature drug implants to deliver minimally fluctuating drug profiles; and implantable visual prostheses devices to deliver useful artificial vision to blind individuals. The company is headquartered in Emeryville, California.

Receive News & Ratings for Vivani Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vivani Medical and related companies with MarketBeat.com's FREE daily email newsletter.